Automated Large Vessel Occlusion Detection Software and Thrombectomy Treatment Times
Publication
Sep 19, 2023
Accelerating the Alzheimer’s disease patient journey with AI-powered disease detection and care coordination
Schedule a meeting
Leading pharma companies need to adapt to changing diagnostic and monitoring practices
Challenges in Prediction, Detection, and Monitoring
Predicting and detecting Alzheimer’s disease in its early stages proves to be challenging due to the disease’s subtle progression without prominent initial symptoms. This complexity in early detection inhibits definitive diagnosis and timely intervention. Furthermore, new Alzheimer’s therapies aimed at slowing cognitive decline require periodic monitoring for amyloid related imaging abnormalities (ARIA) on MRI scans, adding another layer of complexity to Alzheimer’s management.
Navigating Imaging and Therapy Access
Streamlining worklists and communication between treating neurologists and neuroradiologists is crucial in accelerating access to Alzheimer’s therapies. This is where Viz.ai excels.
Optimize HCP workflows. Enhance patient care.
Viz.ai’s AI-powered solutions facilitate every step of the patient journey at the point-of-care, increasing access to life-saving treatments. As a pioneer in advancing detection and care coordination for millions of patients with neurological conditions – including stroke, aneurysm, and hemorrhage – Viz.ai delivers significant value to patients, providers, and pharma partners.
Predict
Leverage the power of AI to analyze clinical data and imaging across healthcare systems, enabling early identification of patients.
Detect
Utilize AI and HIPAA-compliant communication tools to auto-detect suspected Alzheimer’s disease and associated risk-factors, ensuring care activation and next-best-action.
Monitor
Efficiently monitor patients at scale, tracking longitudinal disease progression, risk-factors, and treatment response.
Case Study as a Leader in Cerebral Aneurysm
FDA-cleared Viz Aneurysm software automatically detects suspected cerebral aneurysms and triages patients for proper monitoring and treatment.
28%
increase
Unruptured cerebral aneurysm detection (≥4mm)1
67%
increase
Patients eligible for follow-up1
2.2x
increase
Treatable aneurysms (>7mm)1
Trusted by
1600+
hospitals with users across many specialties and disease areas
Screening 1 patient every
10
seconds
>90%
of alerts viewed within 5 minutes
Backed by robust clinical evidence with
100+
publications and abstracts
Latest Neuro Publications and News
Three New Clinical Studies Presented at the Society of Neurointerventional Surgery Annual Meeting...
Press & NewsReal-world evidence demonstrates the clinical, health equity and patient benefits of AI-powered care coordination. San Francisco, CA – July 31,...
Jul 31, 2023
Schedule a meeting
Experience the power of AI
See for yourself how you can harness the power of AI to accelerate patient access to care through AI-powered care coordination.